ES2075468T3 - Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso. - Google Patents

Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso.

Info

Publication number
ES2075468T3
ES2075468T3 ES91917654T ES91917654T ES2075468T3 ES 2075468 T3 ES2075468 T3 ES 2075468T3 ES 91917654 T ES91917654 T ES 91917654T ES 91917654 T ES91917654 T ES 91917654T ES 2075468 T3 ES2075468 T3 ES 2075468T3
Authority
ES
Spain
Prior art keywords
water
suspended
perfluored
carrier
drug supply
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91917654T
Other languages
English (en)
Inventor
David Louis Meadows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ES2075468T3 publication Critical patent/ES2075468T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PRESENTAN COMPOSICIONES FARMACEUTICAS NO ACUOSAS PARA SU USO EN SISTEMAS FISIOLOGICOS ACUOSOS QUE COMPRENDEN VEHICULOS PARA EL SUMINISTRO DE UNA DROGA SUSPENDIDOS EN PORTADORES LIQUIDOS DE SILICONA FLUORADA O PERFLUOROCARBONO NO ACUOSO. LOS VEHICULOS SUSPENDIDOS PARA EL SUMINISTRO DE LA DROGA PUEDEN SER AGUA LABIL O AGUA ESTABLE E INCORPORAN COMPUESTOS TERAPEUTICOS O PARA EL DIAGNOSTICO QUE PERMANECEN ESTABLES Y SON FARMACOLOGICAMENTE EFECTIVOS DURANTE LARGOS PERIODOS. LAS COMPOSICIONES FARMACEUTICAS POSEEN UNA VIDA MEDIA EXTENDIDA Y NO LIXIBAN LOS COMPUESTOS TERAPEUTICOS O DE DIAGNOSTICO INCORPORADOS EN LOS PORTADORES LIQUIDOS HACIENDOLOS MUY ADECUADOS PARA SU EMPAQUETAMIENTO EN FORMA DE MULTIDOSIS Y PARA SU ADMINISTRACION.
ES91917654T 1990-09-27 1991-09-10 Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso. Expired - Lifetime ES2075468T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/588,697 US5173298A (en) 1990-09-27 1990-09-27 Nonaqueous fluorinated drug delivery vehicle suspensions

Publications (1)

Publication Number Publication Date
ES2075468T3 true ES2075468T3 (es) 1995-10-01

Family

ID=24354930

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91917654T Expired - Lifetime ES2075468T3 (es) 1990-09-27 1991-09-10 Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso.

Country Status (16)

Country Link
US (1) US5173298A (es)
EP (1) EP0550615B1 (es)
JP (1) JP3253072B2 (es)
KR (1) KR100195760B1 (es)
AT (1) ATE125696T1 (es)
AU (1) AU656919B2 (es)
CA (1) CA2090404C (es)
DE (1) DE69111821T2 (es)
ES (1) ES2075468T3 (es)
IE (1) IE69016B1 (es)
IL (1) IL99290A (es)
NZ (1) NZ239558A (es)
PT (1) PT99108B (es)
TW (1) TW224428B (es)
WO (1) WO1992005770A1 (es)
ZA (1) ZA916770B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5660851A (en) * 1989-12-26 1997-08-26 Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem Ocular inserts
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
AU640232B2 (en) * 1990-04-27 1993-08-19 Allergan, Inc. Polymeric drug delivery system
DE4201079C3 (de) * 1992-01-17 1997-09-11 Gramer Eugen Kombinationspräparate zur Augeninnendrucksenkung
AU3924193A (en) * 1992-03-19 1993-10-21 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
ES2179831T3 (es) 1992-09-29 2003-02-01 Inhale Therapeutic Syst Liberacion en los pulmones de fragmentos activos de hormona paratiroidiana.
US5336487A (en) * 1993-03-05 1994-08-09 Refojo Miguel F Method of treating eye disorders with silicon/fluorosilicone copolymer oil
CA2184814A1 (en) 1994-03-04 1995-09-14 Allan S. Hoffman Block and graft copolymers and methods relating thereto
NZ281112A (en) 1994-03-07 1998-04-27 Inhale Therapeutic Syst Powdered insulin delivered as an aerosol
DE4414755C2 (de) * 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
US5661029A (en) * 1994-05-12 1997-08-26 Biomed Biological culture growth and observation device
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
CA2218879A1 (en) * 1995-05-12 1996-11-14 Genentech, Inc. Coarse spray delivery of functional biologic materials
US5667809A (en) * 1995-06-07 1997-09-16 Alliance Pharmaceutical Corp. Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5861175A (en) * 1996-03-15 1999-01-19 Alliance Pharmaceutical Corp. Use of fluorocarbons for diagnosis and treatment of articular disorders
KR20000015944A (ko) * 1996-05-24 2000-03-15 팜 윌리암 엔. 신체 통로의 질병을 치료 또는 예방하기 위한조성물 및 방법
US20030077317A1 (en) * 1996-06-25 2003-04-24 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US5955096A (en) * 1996-06-25 1999-09-21 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
GB9816724D0 (en) * 1998-08-01 1998-09-30 Boots Co Plc Therapeutic agents
KR20010112285A (ko) * 1999-02-23 2001-12-20 추후보충 손상된 신체 통로와 공동의 집결성을 향상시키기 위한조성물 및 방법
ES2525087T5 (es) 2000-05-10 2018-06-28 Novartis Ag Polvos basados en fosfolípidos para administración de fármacos
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CN1204922C (zh) * 2001-02-15 2005-06-08 株式会社三和化学研究所 新的眼科用组合物
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
PT2949658T (pt) 2003-03-03 2018-10-18 Bracco Suisse Sa Péptidos que ligam especificamente o recetor de hgf (cmet) e utilizações dos mesmos
US20050118124A1 (en) * 2003-12-01 2005-06-02 Reinhart Gale M. Compositions for treating keratinous surfaces
JP2008501806A (ja) * 2004-06-08 2008-01-24 オキュラリス ファーマ， インコーポレイテッド 疎水性眼用組成物および使用方法
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
US20070219127A1 (en) * 2006-03-20 2007-09-20 Walt John G Cyclosporin a compositions
KR20100065190A (ko) 2007-09-14 2010-06-15 닛토덴코 가부시키가이샤 약물 담체
US9057712B1 (en) 2011-10-27 2015-06-16 Copilot Ventures Fund Iii Llc Methods of delivery of encapsulated perfluorocarbon taggants
US11904046B1 (en) * 2022-11-14 2024-02-20 Eton Pharmaceuticals, Inc. Hydrocortisone oral liquid formulations
WO2025265050A1 (en) * 2024-06-21 2025-12-26 Insignis Therapeutics, Inc. Liquid epinephrine prodrug formulations and liquid epinephrine formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
US4115544A (en) * 1976-08-18 1978-09-19 Alza Corporation Ocular system made of bioerodible esters having linear ether
GB2070429B (en) * 1979-06-25 1984-05-02 Suntech Use of perfluorocarbon as burn treatment
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
GR78151B (es) * 1982-04-05 1984-09-26 Alcon Lab Inc
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4879304A (en) * 1987-05-01 1989-11-07 Angelini Pharmaceuticals Ltd. Ophthalmic compositions and process for preparing
US4882150A (en) * 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
FR2643572A1 (fr) * 1988-12-22 1990-08-31 Rhone Poulenc Chimie Procede d'encapsulation de particules par pelliculage au moyen d'un copolymere silicone thermoplastique

Also Published As

Publication number Publication date
IL99290A (en) 1996-09-12
JP3253072B2 (ja) 2002-02-04
JPH06501258A (ja) 1994-02-10
CA2090404A1 (en) 1992-03-28
EP0550615A1 (en) 1993-07-14
PT99108B (pt) 1999-02-26
US5173298A (en) 1992-12-22
TW224428B (es) 1994-06-01
EP0550615B1 (en) 1995-08-02
CA2090404C (en) 2001-11-20
IE69016B1 (en) 1996-07-24
ATE125696T1 (de) 1995-08-15
IL99290A0 (en) 1992-07-15
PT99108A (pt) 1993-11-30
ZA916770B (en) 1992-04-29
AU8644291A (en) 1992-04-28
NZ239558A (en) 1993-10-26
DE69111821D1 (de) 1995-09-07
KR100195760B1 (ko) 1999-06-15
DE69111821T2 (de) 1995-12-14
WO1992005770A1 (en) 1992-04-16
AU656919B2 (en) 1995-02-23
IE913379A1 (en) 1992-04-08

Similar Documents

Publication Publication Date Title
ES2075468T3 (es) Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso.
FI902583A7 (fi) Suonensisäinen lääkkeenanto- ja laajennuskatetri
DE69109284D1 (de) Verwendung von fluorierten löslichen tensiden zur herstellung von aerosolarzneimitteln mit dosierter abgabe.
DE69109557D1 (de) Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.
FI954228A0 (fi) Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten
ATE146674T1 (de) Pharmazeutische zusammensetzung zur rektalen verabreichung von wirkstoffen mit topischer medizinischer wirkung im dickdarmniveau
DE69224941D1 (de) Arzneimittelabgabekatheter
DE59009462D1 (de) Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper.
DE3764253D1 (de) Medizinischer saugkoerper mit roentgenkontrastmittel und verfahren zu seiner herstellung.
FI973183A0 (fi) Diagnostiseen kuvantamiseen soveltuvia varjoaineita, joilla on pidentynyt viipymä veressä
DE59101182D1 (de) Körpergewebeverträgliches Glas.
NO905437L (no) Kateteranordning for hindring av blodlekkasje.
IT1128094B (it) Catetere per la somministrazione en dovenosa intermittente di medicamenti
FI940850A7 (fi) Laite lääkkeen annostelemiseksi ihon kautta
DE58903472D1 (de) Implantierbarer injektionskoerper.
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DE58900340D1 (de) Medizinischer katheter fuer die intravaskulaere langzeitinfusion von medikamenten.
MX9203602A (es) Administracion iontoforetica mejorada de farmacos.
DE3575076D1 (de) Katheter fuer rueckinfusion von pharmazeutischen agenten.
DK360188D0 (da) Laegemiddelafgivelsesorgan
ATE113470T1 (de) Gehirnspezifische zubereitung mit gesteuerter abgabe.
FR2796287B1 (fr) Dispositif d'administration de medicament
MY110074A (en) Pharmacuetical formulation.
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
ATE108326T1 (de) Wässerige desmopressin-cmc enthaltende arzneizubereitung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 550615

Country of ref document: ES